Magnetic resonance spectroscopy: Imaging axonal damage in MS

Journal of Neuroimmunology

Volumn 98, Issue 1, 1999, Pages 2-6

  Arnold, D L ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Axons; Magnetic resonance spectroscopy; MRI; Multiple sclerosis

Indexed keywords

CONFERENCE PAPER; DEMYELINATION; DISABILITY; FUNCTIONAL DISEASE; HUMAN; MULTIPLE SCLEROSIS; NERVE GROWTH; NERVE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

AXONS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MULTIPLE SCLEROSIS;

EID: 0033017256     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00074-0     Document Type: Conference Paper

References (22)

1. Anonymous, 1997. Magnetic Resonance in Multiple Sclerosis. Cambridge University Press.
2. Arnold D.L. Reversible reduction of N-acetylaspartate after acute central nervous system in damage. Proc. Soc. Magn. Reson. Med. 1:1992;643-643. Abstract.
3. Arnold D.L., Matthews P.M., Francis G., Antel J. Proton magnetic resonance spectroscopy of human brain in vivo in the evaluation of multiple sclerosis: assessment of the load of disease. Magn. Reson. Med. 14:1990;154-159.
4. Arnold D.L., Matthews P.M., Francis G.S., O'Connor J., Antel J.P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann. Neurol. 31:1992;235-241.
5. Arnold D.L., Riess G.T., Matthews P.M., Francis G.S., Collins D.L., Wolfson C., Antel J.P. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann. Neurol. 36:1994;76-82.
6. Arnold, D.L., Matthews, P.M., De Stefano, N., 1997. In: Bachelard, H.S. (Ed.), MRI and Proton MRS in the Evaluation of Multiple Sclerosis. Plenum, New York, pp. 267-288.
7. Barnes D., Munro P.M.G., Youl B.D., Prineas J.W., McDonald W.I. The longstanding MS lesion; a quantitative MRI and electron microscopic study. Brain. 114:1991;1271-1280.
8. Charcot, J.M., 1868. Histologie de le sclerose en plaques. Gazette des Hopitaux, 554-558.
9. Davie C.A., Hawkins C.P., Barker G.J., Brennan A., Tofts P.S., Miller D.H., McDonald W.I. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 117:1994;49-58.
10. Davie C.A., Barker G.J., Webb S., Tofts P.S., Thompson A.J., Harding A.E., McDonald W.I., Miller D.H. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain. 118:1995;1583-1592.
11. De Stefano N., Francis G., Antel J.P., Arnold D.L. Reversible decreases of N-acetylaspartate in the brain of patients with relapsing remitting multiple sclerosis. Proc. Soc. Magn. Reson. Med. 3:1993;1139-1139. Abstract.
12. De Stefano N., Matthews P.M., Fu L., Narayanan S., Stanley J.A., Francis G.S., Antel J.P., Arnold D.L. Axonal damage correlates with disability in patients with relapsing remitting multiple sclerosis: results of a longitudinal MR spectroscopy study. Brain. 121:1998;1469-1477.
13. Fu L., Matthews P.M., De Stefano N., Worsley K.J., Narayanan S., Francis G.S., Antel J.P., Wolfson C., Arnold D.L. Imaging axonal damage of normal appearing white matter in multiple sclerosis. Brain. 121:1998;103-113.
14. 1H spectroscopic imaging Ann. Neurol. 36:1994;157-165.
15. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
16. Matthews P.M., Francis G., Antel J., Arnold D.L. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis. Neurology. 41:1991;1251-1256. published erratum appears in Neurology 41 (11) (1991) 1828.
17. Raine, C.S., 1997. The neuropathology of multiple sclerosis. In: Raine, C.S., McFarland, H.F., Tourtellotte, W.W. (Eds.), Multiple Sclerosis: Clinical and Pathogenetic Basis. Chapman and Hall, London, pp. 151-171.
18. Redford E.J., Kapoor R., Smith K.J. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain. 120:1997;2149-2157.
19. Rivera-Quinones C.M.D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nature Medicine. 4:1998;187-193.
20. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Lars B. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
21. Waxman S.G. Demyelinating diseases - new pathological insights, new therapeutic targets. N. Engl. J. Med. 338:1998;323-325.
22. Zinman B., Vranic M. Diabetes and exercise. Med. Clin. North Am. 69:1985;145-157. Review.